A progressive neurodegenerative genetic disorder, which affects muscle coordination and some cognitive functions.
The US Food and Drug Administration is allowing biotech company Regenxbio to reapply for licensing of a gene therapy for Hunter syndrome, in a reversal of its previous decision...
The US Food and Drug Administration is allowing biotech company uniQure to reapply for the licensing of a gene therapy that could slow the progression of Huntington's disease...
The first in a series of discussions on human reproduction from the Hastings Centre for Bioethics asks today's most pressing questions about embryo selection…
Clinical embryologist and fertility clinic founder Dr Cristina Hickman shares her thoughts on preimplantation testing for polygenic traits ...
A microRNA treatment is the first therapy to show evidence of slowing Huntington's disease progression....
Genome editing has been used to disrupt a type of repetitive DNA sequence that is found in certain genes and can cause severe neurological disease...
Genes involved in DNA repair have been found to quicken the progression of Huntington's disease...
This online event was an apt and informative discussion of the complex and varied reasons health records are so important to children and young people in adoption, fostering and kinship care...
The recent announcement that a paediatric biobank will be launched in the UK, raises important questions about genetic testing and return of information to participants...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
